Tag: Biotechnology Research

Agilent
United States

Agilent Names Bret DiMarco Chief Legal Officer

SANTA CLARA, Calif. – Agilent Technologies, Inc. (NYSE: A) today announced Bret DiMarco has been named to lead the company’s global legal organization as senior vice president and chief legal officer, as well as serving as secretary. He begins his new role with Agilent effective today. “Bret DiMarco is another outstanding addition to the Agilent leadership team,” said Padraig McDonnell, Agilent president and CEO. “Bret’s … Continue reading Agilent Names Bret DiMarco Chief Legal Officer

Impact Newswire
United States

Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology

Company’s proprietary technology and lab-in-the-loop approach to be applied first to the discovery of novel, solid tumor cell therapies for cancers like pancreatic cancer NEW YORK – Waypoint Bio (aka “Waypoint”), a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, today announced $14.5 million in seed funding led by Hummingbird Ventures with participation from other institutional investors, including Recode … Continue reading Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology

Impact Newswire
X-Chem
United States

X-Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment

Industry Veteran Paul Davie Joins X-Chem Executive Team to Lead Strategic Growth and Partnerships WALTHAM, Mass. – Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer. He will lead global business development, focusing on the creation of new market opportunities for the company’s innovative technology platform and shaping new business ventures, collaborations and strategic partnerships to maximize the … Continue reading X-Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment

Impact Newswire
United States

bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise research and opens new doors for developing effective treatments. CAMBRIDGE, England – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announces the launch … Continue reading bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain

Impact Newswire
Bio-Rad
United States

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

HERCULES, Calif – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024. “We are very pleased to welcome Anette Engelhardt as President of our Clinical Diagnostics Group”Post this Ms. Engelhardt … Continue reading Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Impact Newswire
Biocom California
United States

Tim Scott to Succeed Joe Panetta as Biocom California President and CEO

Panetta to transition to President Emeritus SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO – Biocom California, the association representing the California life science industry, today announced that it has named Tim Scott as its president and CEO, effective January 1, 2025. Mr. Scott will succeed Joe Panetta, Biocom California’s current president and CEO, who has led the organization for 25 years. Mr. … Continue reading Tim Scott to Succeed Joe Panetta as Biocom California President and CEO

Impact Newswire
Vivodyne
United States

Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

PHILADELPHIA – Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development, today announced the appointment of Julie O’Shaughnessy as Chief Operating Officer. In her new role, Julie will oversee business operations, strategic planning, finance, people operations, and multisite expansion, driving the company’s operational excellence and strategic growth initiatives. “Julie has been instrumental in Vivodyne’s growth … Continue reading Vivodyne Appoints Julie O’Shaughnessy as Chief Operating Officer

Impact Newswire
Bruker
United States

Bruker Completes Asset Acquisition of NanoString Business

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis. “We have a proven track record in successfully integrating and nurturing … Continue reading Bruker Completes Asset Acquisition of NanoString Business

Impact Newswire